Your browser doesn't support javascript.
loading
Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.
Kozin, S V; Boucher, Y; Hicklin, D J; Bohlen, P; Jain, R K; Suit, H D.
Affiliation
  • Kozin SV; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Cancer Res ; 61(1): 39-44, 2001 Jan 01.
Article in En | MEDLINE | ID: mdl-11196192
Search on Google
Database: MEDLINE Main subject: Receptors, Growth Factor / Receptor Protein-Tyrosine Kinases / Carcinoma, Small Cell / Glioblastoma / Angiogenesis Inhibitors / Lung Neoplasms / Antibodies, Monoclonal Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2001 Type: Article Affiliation country: United States
Search on Google
Database: MEDLINE Main subject: Receptors, Growth Factor / Receptor Protein-Tyrosine Kinases / Carcinoma, Small Cell / Glioblastoma / Angiogenesis Inhibitors / Lung Neoplasms / Antibodies, Monoclonal Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2001 Type: Article Affiliation country: United States